Patent-family-83151383
Applicants:
- Ascendis Pharma Bone Diseases AS [NORA names: Ascendis Pharma; Private Research]
Abstract
The present application relates to long-acting PTH compounds for reducing Bone Mineral Density (BMD) in patients with increased BMD, as well as specific dosing regimens and other related aspects of such long-acting PTH compounds.
Patent Family Records (1)
Long acting PTH compound treatment
Ascendis Pharma Bone Diseases AS SPROGOEE KENNETT
2024, CN-118234506-A